Phenotypic and genotypic characterization of verotoxin-producing Escherichia coli O103:H2 isolates from cattle and humans

Journal of Clinical Microbiology

Volumn 46, Issue 11, 2008, Pages 3569-3575

  Karama, Musafiri ^a   Johnson, Roger P ^b   Holtslander, Robert ^b   Gyles, Carlton L ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLICIN; HEMOLYSIN; PLASMID DNA;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CATTLE; CONTROLLED STUDY; EHXA GENE; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI O103; GENETIC VARIABILITY; GENOTYPE; NONHUMAN; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; VT1 GENE;

ANIMALS; BACTERIAL TYPING TECHNIQUES; CATTLE; CATTLE DISEASES; CLUSTER ANALYSIS; COLICINS; DNA FINGERPRINTING; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; EUROPE; GENETIC VARIATION; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; NORTH AMERICA; PLASMIDS; SEROTYPING; SHIGA-TOXIGENIC ESCHERICHIA COLI; VIRULENCE FACTORS;

BOS; BOVINAE; ESCHERICHIA COLI;

EID: 55849146219     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01095-08     Document Type: Article

References (46)

1. Anonymous. 2005. European Commission Annual Report. Surveillance of enteric pathogens in Europe and beyond. 1786/2002/EC. International surveillance network for the enteric infections - Salmonella, VTEC O157 and Campylobacter. European Commission, Brussels, Belgium.
2. Bettelheim, K. A., M. A. Hornitzky, and S. P. Djordjevic. 2001. First bovine and ovine isolations of Shiga toxin-producing Escherichia coli O103:H2 in Australia. Aust. Vet. J. 79:289-290.
3. Beutin, L., S. Kaulfuss, S. Herold, E. Oswald, and H. Schmidt. 2005. Genetic analysis of enteropathogenic and enterohemorrhagic Escherichia coli serogroup O103 strains by molecular typing of virulence and housekeeping genes and pulsed-field gel electrophoresis. J. Clin. Microbiol. 43:1552-1563.
4. Beutin, L., G. Krause, S. Zimmermann, S. Kaulfuss, and K. Gleier. 2004. Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period. J. Clin. Microbiol. 42:1099-1108.
5. Beutin, L., M. A. Montenegro, I. Orskov, F. Orskov, J. Prada, S. Zimmermann, and R. Stephan. 1989. Close association of verotoxin (Shiga-like toxin) production with enterohemolysin production in strains of Escherichia coli. J. Clin. Microbiol. 27:2559-2564.
6. - strains and a source of human diseases. J. Clin. Microbiol. 38: 3470-3473.
7. Blanco, J., E. A. Gonzalez, S. Garcia, M. Blanco, B. Regueiro, and I. Bernardez. 1988. Production of toxins by Escherichia coli strains isolated from calves with diarrhoea in Galicia (north-western Spain). Vet. Microbiol. 18: 297-311.
8. Brooks, J. T., E. G. Sowers, J. G. Wells, K. D. Greene, P. M. Griffin, R. M. Hoekstra, and N. A. Strockbine. 2005. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. J. Infect. Dis. 192:1422-1429.
9. Brunder, W., H. Schmidt, and H. Karch. 1997. EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7 cleaves human coagulation factor V. Mol. Microbiol. 24:767-778.
10. Brunder, W., H. Schmidt, and H. Karch. 1996. KatP, a novel catalase-peroxidase encoded by the large plasmid of enterohaemorrhagic Escherichia coli O157:H7. Microbiology 142:3305-3315.
11. Centers for Disease Control and Prevention. 2007. Laboratory-confirmed non-O157 Shiga toxin-producing Escherichia coli - Connecticut, 2000-2005. MMWR Morb. Mortal. Wkly. Rep. 56:29-31.
12. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standards, 2nd ed. M31-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
13. DesRosiers, A., J. M. Fairbrother, R. P. Johnson, C. Desautels, A. Letellier, and S. Quessy. 2001. Phenotypic and genotypic characterization of Escherichia coli verotoxin-producing isolates from humans and pigs. J. Food Prot. 64:1904-1911.
14. Duhamel, G. E., R. A. Moxley, C. W. Maddox, and E. D. Erickson. 1992. Enteric infection of a goat with enterohemorrhagic Escherichia coli (O103: H2). J. Vet. Diagn. Investig. 4:197-200.
15. Eklund, M., F. Scheutz, and A. Siitonen. 2001. Clinical isolates of non-O157 Shiga toxin-producing Escherichia coli: serotypes, virulence characteristics, and molecular profiles of strains of the same serotype. J. Clin. Microbiol. 39:2829-2834.
16. Fey, P. D., R. S. Wickert, M. E. Rupp, T. J. Safranek, and S. H. Hinrichs. 2000. Prevalence of non-O157:H7 Shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska. Emerg. Infect. Dis. 6:530-533.
17. Gerner-Smidt, P., K. Hise, J. Kincaid, S. Hunter, S. Rolando, E. Hyytia-Trees, E. M. Ribot, B. Swaminathan, and the PulseNet Taskforce. 2006. PulseNet USA: a five-year update. Foodborne Pathog. Dis. 3:9-19.
18. Guth, B. E., T. M. Vaz, T. A. Gomes, S. H. Chinarelli, M. M. Rocha, A. F. de Castro, and K. Irino. 2005. Re-emergence of O103:H2 Shiga toxin-producing Escherichia coli infections in Sao Paulo, Brazil. J. Med. Microbiol. 54: 805-806.
19. Johnson, K. E., C. M. Thorpe, and C. L. Sears. 2006. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin. Infect. Dis. 43:1587-1595.
20. Karmali, M. A., M. Mascarenhas, S. Shen, K. Ziebell, S. Johnson, R. Reid-Smith, J. Isaac-Renton, C. Clark, K. Rahn, and J. B. Kaper. 2003. Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J. Clin. Microbiol. 41:4930-4940.
21. Kijima-Tanaka, M., K. Ishihara, A. Morioka, A. Kojima, T. Ohzono, K. Ogikubo, T. Takahashi, and Y. Tamura. 2003. A national surveillance of antimicrobial resistance in Escherichia coli isolated from food-producing animals in Japan. J. Antimicrob. Chemother. 51:447-451.
22. - in Germany - a ten-year study. Int. J. Med. Microbiol. 290:269-278.
23. Lockary, V. M., R. F. Hudson, and C. L. Ball. 2007. Shiga toxin-producing Escherichia coli, Idaho. Emerg. Infect. Dis. 13:1262-1264.
24. Mariani-Kurkdjian, P., E. Denamur, A. Milon, B. Picard, H. Cave, N. Lambert-Zechovsky, C. Loirat, P. Goullet, P. J. Sansonetti, and J. Elion. 1993. Identification of a clone of Escherichia coli O103:H2 as a potential agent of hemolytic-uremic syndrome in France. J. Clin. Microbiol. 31:296-301.
25. Mora, A., J. E. Blanco, M. Blanco, M. P. Alonso, G. Dhabi, A. Echeita, E. A. Gonzalez, M. I. Bernardez, and J. Blanco. 2005. Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain. Res. Microbiol. 156:793-806.
26. Morabito, S., H. Karch, H. Schmidt, F. Minelli, P. Mariani-Kurkdjian, F. Allerberger, K. A. Bettelheim, and A. Caprioli. 1999. Molecular characterisation of verocytotoxin-producing Escherichia coli of serogroup O111 from different countries. J. Med. Microbiol. 48:891-896.
27. Nataro, J. P., and J. B. Kaper. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11:142-201.
28. Ogura, Y., K. Kurokawa, T. Ooka, K. Tashiro, T. Tobe, M. Ohnishi, K. Nakayama, T. Morimoto, J. Terajima, H. Watanabe, S. Kuhara, and T. Hayashi. 2006. Complexity of the genomic diversity in enterohemorrhagic Escherichia coli O157 revealed by the combinational use of the O157 Sakai OligoDNA microarray and the Whole Genome PCR scanning. DNA Res. 13:3-14.
29. Ohnishi, M., K. Kurokawa, and T. Hayashi. 2001. Diversification of Escherichia coli genomes: are bacteriophages the major contributors? Trends Microbiol. 9:481-485.
30. Ostroff, S. M., P. I. Tarr, M. A. Neill, J. H. Lewis, N. Hargrett-Bean, and J. M. Kobayashi. 1989. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J. Infect. Dis. 160:994-998.
31. Oswald, E., H. Schmidt, S. Morabito, H. Karch, O. Marches, and A. Caprioli. 2000. Typing of 8472intimin genes in human and animal enterohemorrhagic and enteropathogenic Escherichia coli: characterization of a new intimin variant. Infect. Immun. 68:64-71.
32. Pai, C. H., N. Ahmed, H. Lior, W. M. Johnson, H. V. Sims, and D. E. Woods. 1988. Epidemiology of sporadic diarrhea due to verocytotoxin- producing Escherichia coli: a two-year prospective study. J. Infect. Dis. 157:1054-1057.
33. Paros, M., P. I. Tarr, H. Kim, T. E. Besser, and D. D. Hancock. 1993. A comparison of human and bovine Escherichia coli O157:H7 isolates by toxin genotype, plasmid profile, and bacteriophage lambda-restriction fragment length polymorphism profile. J. Infect. Dis. 168:1300-1303.
34. O157. J. Clin. Microbiol. 36:598-602.
35. - in Germany. Infect. Genet. Evol. 1:265-275.
36. Pugsley, A. P., and B. Oudega. 1987. Methods of studying colicins and their plasmids, p. 105-161. In K. G. Hardy (ed.), Plasmids: a practical approach. IRL Press, Oxford, England.
37. Ratnam, S., S. B. March, R. Ahmed, G. S. Bezanson, and S. Kasatiya. 1988. Characterization of Escherichia coli serotype O157:H7. J. Clin. Microbiol. 26:2006-2012.
38. Schmidt, H., B. Henkel, and H. Karch. 1997. A gene cluster closely related to type II secretion pathway operons of gram-negative bacteria is located on the large plasmid of enterohemorrhagic Escherichia coli O157 strains. FEMS Microbiol. Lett. 148:265-272.
39. Schmidt, H., L. Beutin, and H. Karch. 1995. Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933. Infect. Immun. 63:1055-1061.
40. Schmidt, H., E. Maier, H. Karch, and R. Benz. 1996. Pore-forming properties of the plasmid-encoded hemolysin of enterohemorrhagic Escherichia coli O157:H7. Eur. J. Biochem. 241:594-601.
41. Schmidt, H., C. Geitz, P. I. Tarr, M. Frosch, and H. Karch. 1999. Non-O157:H7 pathogenic Shiga toxin-producing Escherichia coli: phenotypic and genetic profiling of virulence traits and evidence for clonality. J. Infect. Dis. 179:115-123.
42. Sonntag, A. K., R. Prager, M. Bielaszewska, W. Zhang, A. Fruth, H. Tschape, and H. Karch. 2004. Phenotypic and genotypic analyses of enterohemorrhagic Escherichia coli O145 strains from patients in Germany. J. Clin. Microbiol. 42:954-962.
43. Tarr, P. I., L. S. Fouser, A. E. Stapleton, R. A. Wilson, H. H. Kim, J. C. Vary, Jr., and C. R. Clausen. 1996. Hemolytic-uremic syndrome in a six-year-old girl after a urinary tract infection with Shiga-toxin-producing Escherichia coli O103:H2. N. Engl. J. Med. 335:635-638.
44. Tozzi, A. E., A. Caprioli, F. Minelli, A. Gianviti, L. De Petris, A. Edefonti, G. Montini, A. Ferretti, T. De Palo, M. Gaido, G. Rizzoni, and the Hemolytic Uremic Syndrome Study Group. 2003. Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000. Emerg. Infect. Dis. 9:106-108.
45. Vidovic, S., and D. R. Korber. 2006. Prevalence of Escherichia coli O157 in Saskatchewan cattle: characterization of isolates by using random amplified polymorphic DNA PCR, antibiotic resistance profiles, and pathogenicity determinants. Appl. Environ. Microbiol. 72:4347-4355.
46. Zhang, W. L., M. Bielaszewska, A. Liesegang, H. Tschäpe, H. Schmidt, M. Bitzan, and H. Karch. 2000. Molecular characteristics and epidemiological significance of Shiga toxin-producing Escherichia coli O26. J. Clin. Microbiol. 38:2134-2140.